Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluation of Affordability and Impoverishment Effect of Cardiovascular Medicines in Iran



Vasheghani Farahani A1 ; Reza Rasekh H1 ; Najafi S2 ; Rahimi F1 ; Akbari M2 ; Salehnia F2 ; Hemati H2 ; Jalali F2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmacoeconomics and Pharmaceutical Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. College of Pharmacy, Tehran University of medical science, Tehran, Iran

Source: Iranian Journal of Pharmaceutical Sciences Published:2018

Abstract

Cardiovascular disease is one of the most important causes of death in the world. There are variety of plans and strategies to treatment and prevention of CVD. Medicines have significant role in reaching the goals. Ensuring affordability of medicines is very crucial to success in these programs. The impoverishment method which focuses on the impoverishing effect of the purchasing of medicines is one of the most popular methods to quantifying affordability of medicines. We applied this method to measure affordability of cardiovascular medicines in Iran. We used two poverty lines 1.25 USD and 2 USD per day which are recommended by World Bank to access the affordability of medicines. Mono therapy with one anti platelet, Beta blocker, ACE inhibitor and Statin as well as combination therapy have been determined. Our study highlighted that the poorest households in Iran would be at risk of pushing under poverty line because of price of the medicines. © 2018, Iranian Association of Pharmaceutical Scientists. All rights reserved.
Related Docs
View other Related Docs
1. Essential Medicines for Universal Health Coverage, The Lancet (2017)
2. Essential Medicines for Universal Health Coverage; [Основные (Жизненно Важные) Лекарства Для Всеобщего Охвата Медицинской Помощью], Kazan Medical Journal (2019)
3. Investigating the Exposure of Iranian Households to Catastrophic Health Expenditure Due to the Need to Purchase Medicines, PLoS ONE (2019)
4. The Availability and Affordability of Cardiovascular Medicines for Secondary Prevention in Tehran Province (Iran), Iranian Journal of Pharmaceutical Research (2018)
5. Public Sector Capacity to Prevent and Control of Noncommunicable Diseases in Twelve Low- and Middle-Income Countries Based on Who-Pen Standards: A Systematic Review, Health Services Insights (2021)
6. Reasons for Poor Blood Pressure Control in Eastern Sub-Saharan Africa: Looking Into 4P’S (Primary Care, Professional, Patient, and Public Health Policy) for Improving Blood Pressure Control: A Scoping Review, BMC Cardiovascular Disorders (2021)
7. Providing a Framework for Assessment of the Access to Medicine, DARU# Journal of Pharmaceutical Sciences (2019)
8. Studying the Impoverishing Effects of Procuring Medicines: A National Study, BMC International Health and Human Rights (2019)
Experts (# of related papers)
View all Related Experts
Arash Rashidian (2)
Shekoufeh Nikfar (1)
Other Related Docs
9. Availability and Affordability of Cardiovascular Medicines in a Major City of Afghanistan in 2020, DARU# Journal of Pharmaceutical Sciences (2022)